Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H.

Am J Hum Genet. 2006 Oct;79(4):752-8. Epub 2006 Aug 17.

2.

Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.

Bar-Shira A, Hutter CM, Giladi N, Zabetian CP, Orr-Urtreger A.

Neurogenetics. 2009 Oct;10(4):355-8. doi: 10.1007/s10048-009-0186-0. Epub 2009 Mar 13.

PMID:
19283415
3.

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N.

Neurology. 2007 Oct 16;69(16):1595-602.

PMID:
17938369
4.

LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century.

Lesage S, Leutenegger AL, Ibanez P, Janin S, Lohmann E, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group.

Am J Hum Genet. 2005 Aug;77(2):330-2. No abstract available.

5.

Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans.

Lesage S, Patin E, Condroyer C, Leutenegger AL, Lohmann E, Giladi N, Bar-Shira A, Belarbi S, Hecham N, Pollak P, Ouvrard-Hernandez AM, Bardien S, Carr J, Benhassine T, Tomiyama H, Pirkevi C, Hamadouche T, Cazeneuve C, Basak AN, Hattori N, Dürr A, Tazir M, Orr-Urtreger A, Quintana-Murci L, Brice A; French Parkinson's Disease Genetics Study Group.

Hum Mol Genet. 2010 May 15;19(10):1998-2004. doi: 10.1093/hmg/ddq081. Epub 2010 Mar 2.

PMID:
20197411
6.

Genetic screening of the G2019S mutation of the LRRK2 gene in Southwest European, North African, and Sephardic Jewish subjects.

Change N, Mercier G, Lucotte G.

Genet Test. 2008 Sep;12(3):333-9. doi: 10.1089/gte.2007.0098.

PMID:
18666856
7.

LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.

Bardien S, Marsberg A, Keyser R, Lombard D, Lesage S, Brice A, Carr J.

J Neural Transm (Vienna). 2010 Jul;117(7):847-53. doi: 10.1007/s00702-010-0423-6. Epub 2010 Jun 11.

PMID:
20544233
8.

A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease.

Warren L, Gibson R, Ishihara L, Elango R, Xue Z, Akkari A, Ragone L, Pahwa R, Jankovic J, Nance M, Freeman A, Watts RL, Hentati F.

Parkinsonism Relat Disord. 2008;14(1):77-80. Epub 2007 Apr 11.

PMID:
17433753
9.

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.

Neurology. 2006 Nov 28;67(10):1786-91. Epub 2006 Oct 18.

PMID:
17050822
10.

LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.

Dupré N, Rivière JB, Myers RH, Provencher P, Pourcher E, Emond F, Rouleau GA.

Can J Neurol Sci. 2007 Aug;34(3):333-5.

PMID:
17803032
11.

Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.

Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Gómez-Esteban JC, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP.

Neurogenetics. 2009 Oct;10(4):347-53. doi: 10.1007/s10048-009-0187-z. Epub 2009 Mar 24.

12.

The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

Thaler A, Ash E, Gan-Or Z, Orr-Urtreger A, Giladi N.

J Neural Transm (Vienna). 2009 Nov;116(11):1473-82. doi: 10.1007/s00702-009-0303-0. Review.

PMID:
19756366
13.

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M.

Am J Hum Genet. 2005 Apr;76(4):672-80. Epub 2005 Feb 22.

14.

A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype.

Pirkevi C, Lesage S, Condroyer C, Tomiyama H, Hattori N, Ertan S, Brice A, Başak AN.

Neurogenetics. 2009 Jul;10(3):271-3. doi: 10.1007/s10048-009-0173-5. Epub 2009 Jan 27.

PMID:
19172321
15.

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.

Hassin-Baer S, Laitman Y, Azizi E, Molchadski I, Galore-Haskel G, Barak F, Cohen OS, Friedman E.

J Neurol. 2009 Mar;256(3):483-7. doi: 10.1007/s00415-009-0117-x. Epub 2009 Mar 24.

PMID:
19412725
16.

Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism.

Eblan MJ, Scholz S, Stubblefield B, Gutti U, Goker-Alpan O, Hruska KS, Singleton AB, Sidransky E.

Neurosci Lett. 2006 Aug 14;404(1-2):163-5. Epub 2006 Jun 15.

PMID:
16781064
17.

LRRK2 G2019S founder haplotype in the Chinese population.

Tan EK, Skipper L, Tan L, Liu JJ.

Mov Disord. 2007 Jan;22(1):105-7.

PMID:
17083102
18.

The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction.

Gan-Or Z, Bar-Shira A, Mirelman A, Gurevich T, Giladi N, Orr-Urtreger A.

J Mol Neurosci. 2012 Mar;46(3):541-4. doi: 10.1007/s12031-011-9641-0. Epub 2011 Sep 6.

PMID:
21898123
19.

LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay.

Mata IF, Cosentino C, Marca V, Torres L, Mazzetti P, Ortega O, Raggio V, Aljanati R, Buzó R, Yearout D, Dieguez E, Zabetian CP.

Parkinsonism Relat Disord. 2009 Jun;15(5):370-3. doi: 10.1016/j.parkreldis.2008.09.002. Epub 2008 Nov 5.

PMID:
18980856
20.

Genetic analysis of LRRK2 mutations in patients with Parkinson disease.

Deng H, Le W, Guo Y, Hunter CB, Xie W, Huang M, Jankovic J.

J Neurol Sci. 2006 Dec 21;251(1-2):102-6. Epub 2006 Nov 9.

PMID:
17097110

Supplemental Content

Support Center